- Home
- CMRX vs ARMN Comparison
CMRX vs ARMN Comparison
Compare CMRX & ARMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRX
- ARMN
- Stock Information
- Founded
- CMRX 2000
- ARMN 1992
- Country
- CMRX United States
- ARMN Canada
- Employees
- CMRX N/A
- ARMN N/A
- Industry
- CMRX Biotechnology: Pharmaceutical Preparations
- ARMN
- Sector
- CMRX Health Care
- ARMN
- Exchange
- CMRX Nasdaq
- ARMN Nasdaq
- Market Cap
- CMRX 797.3M
- ARMN 769.7M
- IPO Year
- CMRX 2013
- ARMN N/A
- Fundamental
- Price
- CMRX $8.54
- ARMN $5.44
- Analyst Decision
- CMRX Hold
- ARMN
- Analyst Count
- CMRX 4
- ARMN 0
- Target Price
- CMRX $8.51
- ARMN N/A
- AVG Volume (30 Days)
- CMRX 2.0M
- ARMN 1.4M
- Earning Date
- CMRX 04-30-2025
- ARMN 05-13-2025
- Dividend Yield
- CMRX N/A
- ARMN N/A
- EPS Growth
- CMRX N/A
- ARMN 77.15
- EPS
- CMRX N/A
- ARMN 0.14
- Revenue
- CMRX $212,000.00
- ARMN $510,604,000.00
- Revenue This Year
- CMRX $2,416.04
- ARMN $49.45
- Revenue Next Year
- CMRX $923.92
- ARMN $4.63
- P/E Ratio
- CMRX N/A
- ARMN $37.97
- Revenue Growth
- CMRX N/A
- ARMN 14.06
- 52 Week Low
- CMRX $0.75
- ARMN $3.29
- 52 Week High
- CMRX $8.55
- ARMN $5.49
- Technical
- Relative Strength Index (RSI)
- CMRX 80.86
- ARMN 66.97
- Support Level
- CMRX $8.50
- ARMN $5.14
- Resistance Level
- CMRX $8.55
- ARMN $5.65
- Average True Range (ATR)
- CMRX 0.02
- ARMN 0.30
- MACD
- CMRX -0.12
- ARMN 0.07
- Stochastic Oscillator
- CMRX 88.89
- ARMN 85.31
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
About ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development and operation of gold properties in Colombia, Guyana and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, Toroparu Project in Guyana and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.